Quick Heal Technologies Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹65 Cr −22.3% YoYSee revenue, profit and what management said. You are viewing Q3 FY26.
QH

Quick Heal Technologies Ltd

Q3 FY26IT - Software

Quick Heal Technologies Q3 FY26: Revenue ₹71.5 Cr, PAT ₹6.6 Cr

Q3 FY26 investor presentation: what the company reported on revenue, margins and capex.

Revenue
₹72Cr
+1.3% YoY
−14.3% QoQ
Net profit
₹7Cr
+5909.1% YoY
−16.4% QoQ
Margin
0.63%
+6 pp YoY
−10.4 pp QoQ

Based on Quick Heal Technologies Ltd's Q3 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹148
Market cap₹827 Cr

The short version

Q3 FY26 Net Revenue: ₹71.5 Cr, up 1.3% YoY (Page 18) - Enterprise Revenue Q3 FY26: ₹38.5 Cr, up 37.1% YoY (Page 18) - Consumer Revenue Q3 FY26: ₹37.6 Cr, down 21.2% YoY (Page 18) - 9M FY26 Net Revenue: ₹212.3 Cr, down 1.0% YoY (Page 19) - 9M FY26 Enterprise Revenue: ₹107.1 Cr, up 20.4% YoY (Page 19) - 9M FY26 Consumer Revenue: ₹128.8 Cr, down 12.1% YoY (Page 19) Q3 FY26 Financials: - EBITDA: ₹0.5 Cr, up 111.9% YoY (Page 18) - EBITDA Margin: 0.6% (Page 28) - Profit After Tax (PAT): ₹6.6 Cr, up 5909.1% YoY (Page 18) - PAT Margin: 9.2% (Page 28) - Revenue: ₹71.5 Cr, up 1.3% YoY (Page 18)

From Quick Heal Technologies Ltd's Q3 FY26 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

  • Q3 FY26 Net Revenue: ₹71.5 Cr, up 1.3% YoY (Page 18)
  • Enterprise Revenue Q3 FY26: ₹38.5 Cr, up 37.1% YoY (Page 18)
  • Consumer Revenue Q3 FY26: ₹37.6 Cr, down 21.2% YoY (Page 18)
  • 9M FY26 Net Revenue: ₹212.3 Cr, down 1.0% YoY (Page 19)

2 more points from Quick Heal Technologies Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Quick Heal Technologies Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

It focuses on financial performance, business highlights, marketing campaigns, product strategies, market expansion, and leadership without reference to specific capital expenditure or physical expansion projects.

Top-ranked in IT - Software

Ranked on what management guided this quarter

Guidance-ranked
1Workmates Core2
Rev 1Mar 1
2Virtual Galaxy
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 1
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Quick Heal Technologies Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • The presentation reports an order book of INR 80 Crore+.
  • It mentions INR 64 Crore order received with a 5-year fulfillment period for implementing integrated cybersecurity solutions.
  • Deferred revenue stands at approximately INR 20 Crore.

Quick Heal Technologies Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Quick Heal Technologies Ltd Q3 FY26 results — key figures

Quick Heal Technologies Ltd Q3 FY26 reported results vs Q3 FY25, ₹ crore
₹ CrQ3 FY26Q3 FY25YoYQ2 FY26QoQ
Revenue7271+1.3%84-14.3%
Operating profit (EBITDA)0-4—9-95.1%
Operating margin0.63%-5.34%+6 pp11.05%-10.4 pp
Profit before tax6-2—10-44.1%
Net profit (PAT)70+5909.1%8-16.4%
EPS (₹)1.220.02+6000%1.46-16.4%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹65 Cr, net profit ₹6 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in IT - Software this season

  • XT Global Infotech (Q3 FY26)

    Q3 FY26 Consolidated Revenue: ₹92.5 Cr, down 2.0% year-on-year (YoY) as per page 14. Key investor presentation takeaways from XT Global Infotech's Q3 FY26 inves

  • 3i Infotech (Q3 FY26)

    Q3 FY26 consolidated operating revenue: ₹172.1 crore, a 1.6% decrease QoQ (Page 3, Page 22). Key investor presentation takeaways from 3i Infotech Ltd's Q3 FY26

  • Xelpmoc Design (Q3 FY26)

    Operating Revenue for Q3 FY26: Rs 11.2 million, up 34.5% year-on-year (Q3 FY25: Rs 8.3 million). Key investor presentation takeaways from Xelpmoc Design's Q3 FY

  • Cybertech Systems & Software (Q3 FY26)

    Q3FY26 Operating Revenue: ₹578.4 million, down 1.3% YoY (from ₹585.7 million in Q3FY25). Key investor presentation takeaways from Cybertech Systems & Software L

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Quick Heal Technologies Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Quick Heal Technologies Ltd Q3 FY26 results?

Q3 FY26 Net Revenue: ₹71.5 Cr, up 1.3% YoY (Page 18) - Enterprise Revenue Q3 FY26: ₹38.5 Cr, up 37.1% YoY (Page 18) - Consumer Revenue Q3 FY26: ₹37.6 Cr, down 21.2% YoY (Page 18) - 9M FY26 Net Revenue: ₹212.3 Cr, down 1.0% YoY (Page 19) - 9M FY26 Enterprise Revenue: ₹107.1 Cr, up 20.4% YoY (Page 19) - 9M FY26 Consumer Revenue: ₹128.8 Cr, down 12.1% YoY (Page 19) Q3 FY26 Financials: - EBITDA: ₹0.5 Cr, up 111.9% YoY (Page 18) - EBITDA Margin: 0.6% (Page 28) - Profit After Tax (PAT): ₹6.6 Cr, up 5909.1% YoY (Page 18) - PAT Margin: 9.2% (Page 28) - Revenue: ₹71.5 Cr, up 1.3% YoY (Page 18)

What is Quick Heal Technologies Ltd share price analysis?

Quick Heal Technologies Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹827 Cr. Investors should review the full earnings analysis for detailed insights.

Keep Quick Heal Technologies Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.